Ultrasound Guided Nerve Block for Hip Fracture Pain Management at Emergency Department

June 1, 2022 updated by: Borja Alcobía-Díaz MD, PhD, Hospital San Carlos, Madrid
The main objective is to determine if ultrasound guided suprainguinal iliac fascia block leads in better clinical outcomes such as pain management or time to home discharge.

Study Overview

Detailed Description

Determining effectiveness in ultrasound guided suprainguinal iliac fascia block as a tool of comfortability of patients with less use of opioids and their side effects and its possible influence in early discharge to home has no evidence in orthopedics literature till today.

Ultrasound becomes an accessible tool at Emergency Departments and Orthopedic Surgeons are increasingly interested its clinical use.

This clinical trial wants to investigate if its use for hip nerve block leads in better clinical outcomes such as pain management or time to home discharge.

Study Type

Interventional

Enrollment (Anticipated)

72

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Low energy Hip Fracture

Exclusion Criteria:

  • Don´t meet Inclusion Criteria
  • Present any other synchronic fracture.
  • Drug allergy for drugs used for nerve blocking
  • Skin infection at injection site.
  • Contraindication due to comorbidities.
  • Pathologic fractures.
  • Cognitive impairment
  • Do not give his consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
NO_INTERVENTION: No Nerve Blocking
Pain management at ER Department will be as usually with iv drugs and 3 kilogram soft traction.
ACTIVE_COMPARATOR: Ultrasound Nerve blocking
Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.
Pain management at ER Department will be as usually with iv drugs and ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Control after Ultrasound guided nerve block vs iv painkillers
Time Frame: During Emergency Department stay (up to 12 hours)
Using Visual Analogue Scale (1-No pain; 10 -worst pain) measure difference between pain during arrival at Emergency Department and 30 minutes after Ultrasound guided nerve block vs iv painkillers
During Emergency Department stay (up to 12 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Hip Mobility with tolerable pain
Time Frame: Immediately Before Discharging home assessed up to 2 weeks.
Range of Motion Degrees
Immediately Before Discharging home assessed up to 2 weeks.
Functionality: Sit to Stand Test
Time Frame: Immediately Before Discharging home assessed up to 2 weeks.
The 30-second chair stand involves recording the number of stands a person can complete in 30 seconds
Immediately Before Discharging home assessed up to 2 weeks.
Opioid Use
Time Frame: Immediately Before Discharging home assessed up to 2 weeks.
Quantity of Opioid drugs consumed during Hospital stay expressed in Morphine equivalent doses
Immediately Before Discharging home assessed up to 2 weeks.
Patient Satisfaction
Time Frame: Immediately Before Discharging home assessed up to 2 weeks.
Patient subjective satisfaction in a numeric scale from 1 (completely dissatisfied with pain management) to 10 (highest possible satisfaction with pain management).
Immediately Before Discharging home assessed up to 2 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Borja Alcobía-Díaz, MD, PhD, Clinical Assistant

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

June 1, 2022

Primary Completion (ANTICIPATED)

December 1, 2022

Study Completion (ANTICIPATED)

February 1, 2023

Study Registration Dates

First Submitted

February 25, 2022

First Submitted That Met QC Criteria

June 1, 2022

First Posted (ACTUAL)

June 3, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 3, 2022

Last Update Submitted That Met QC Criteria

June 1, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Email Contact

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Ultrasound guided Suprainguinal Iliac Fascia Nerve Block.

3
Subscribe